OTCMKTS:KNWN Know Labs (KNWN) Stock Price, News & Analysis → Altcoin FRENZY Alert… (From Crypto 101 Media) (Ad) Free KNWN Stock Alerts $0.63 -0.01 (-1.56%) (As of 03/28/2024 ET) Add Compare Share Share Today's Range$0.62▼$0.6450-Day Range$0.40▼$0.9052-Week Range$1.15▼$4.00Volume28,307 shsAverage Volume60,338 shsMarket Capitalization$27.64 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsHeadlinesSEC FilingsStock AnalysisChartFinancialsHeadlinesSEC Filings Get Know Labs alerts: Email Address Ad WealthPressA lot of people are making this costly mistakeYou may have heard the saying “options are risky” … And, they can be. But only if you use them the way a lot of folks do. A lot of people think of BUYING speculative options when they talk about options. And BUYING low probability, speculative options is definitely risky… It’s how some folks leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. Click here to jump in on the next one About Know Labs Stock (OTCMKTS:KNWN)Know Labs, Inc. focuses on the development and commercialization of proprietary technologies in the United States. Its technology uses spectroscopy to direct electromagnetic energy through a substance or material to capture a molecular signature. The company refers to its technology as Bio-RFID. The Bio-RFID technology can be integrated into various wearable, mobile, or bench-top form factors. Its first application of Bio-RFID technology is a product marketed as a glucose monitor that provide the user with real time information on their blood glucose levels. The company was formerly known as Visualant, Incorporated and changed its name to Know Labs, Inc. in May 2018. Know Labs, Inc. was founded in 1998 and is headquartered in Seattle, Washington.Read More KNWN Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart KNWN Stock News HeadlinesMarch 29, 2024 | msn.comElon Musk Makes Grok AI Available to All Paying X Subscribers: What to KnowMarch 29, 2024 | cbsnews.comAlleged drug lab producing DMT discovered in BrentwoodMarch 29, 2024 | WealthPress (Ad)A lot of people are making this costly mistakeYou may have heard the saying “options are risky” … And, they can be. But only if you use them the way a lot of folks do. A lot of people think of BUYING speculative options when they talk about options. And BUYING low probability, speculative options is definitely risky… It’s how some folks leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. March 28, 2024 | msn.com65 and Working? Here's Everything You Need to Know About Medicare EnrollmentMarch 28, 2024 | nytimes.comWhat We Know About the Francis Scott Key Bridge Collapse in BaltimoreMarch 28, 2024 | msn.comStar Trek: Strange New Worlds Season 3 First Image Reveals Spock In New Costume & Science LabMarch 28, 2024 | news.yahoo.comDo You Know Where Your Strawberries Come From?March 28, 2024 | msn.comUGA Coastal Ecology Lab saves gator from tomato cageMarch 29, 2024 | MarketBeat (Ad)Your $200 account credit is about to expireUpdate to MarketBeat All Access and Save $300 on Your Annual SubscriptionMarch 22, 2024 | msn.comUtica's cannabis industry gets a boost with new testing facility. What you need to knowMarch 20, 2024 | msn.comGroover Labs co-founder Curt Gridley was 'what a liberal arts person should be like'March 20, 2024 | finance.yahoo.com7 Tips for Choosing a Lab and Testing Your WastewaterMarch 20, 2024 | techcrunch.comAstera Labs’ IPO pops 54%, showing that investor demand for tech with an AI twist is highMarch 19, 2024 | msn.comDiamond Can Be Squeezed Into Something Even Harder. Now We Know How to Do It.March 18, 2024 | msn.comA Lab Says Benzoyl Peroxide in Acne Products May Cause Cancer. But Experts Don’t AgreeMarch 18, 2024 | cbsnews.comAncient gars studied at new University of Minnesota lab in hopes of unlocking secrets of longevityMarch 18, 2024 | msn.com4 things to know about California Senate Democrats’ plan to fix the budget deficitMarch 18, 2024 | msn.comMarquel Martin’s 3Point0 Labs Acquires Thirty There Media, Digital Agency Of Former UFC Social Media Director Randy FaehnrichMarch 18, 2024 | dallasnews.comWhat college-bound Texas students and families should know about FAFSA delaysMarch 16, 2024 | msn.comFake eclipse glasses have caused alarm. Here's what to know for April's total eclipse.March 15, 2024 | msn.comWhich eclipse glasses are safe? What to know about scams ahead of April 8 solar eclipseMarch 15, 2024 | msn.comCOVID Lab Leak Theory Resurfaces After Controversial New StudyMarch 14, 2024 | finance.yahoo.comTerraform Labs retains Dentons as legal counsel amid bankruptcyMarch 13, 2024 | msn.comNew species found in Great Salt Lake changes what we know about its ecosystemMarch 13, 2024 | msn.comHIV prevention drugs known as PrEP are highly effective, but many at risk don't know about itMarch 13, 2024 | msn.comWhen will we know who made it to the Sacramento mayoral runoff?March 13, 2024 | msn.comBubonic plague kills New Mexico man, officials say. What to know about the ‘Black Death’See More Headlines Receive KNWN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Know Labs and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/07/2019Today3/29/2024Fiscal Year End9/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorBusiness Services Industry Measuring & Controlling Devices Sub-IndustryN/A Current SymbolOTCMKTS:KNWN CUSIPN/A CIK1074828 Webwww.knowlabs.co Phone(206) 903-1351Fax206-826-0451Employees12Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.60) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-25,360,000.00 Net MarginsN/A Pretax Margin-506.81% Return on Equity-907.68% Return on Assets-176.55% Debt Debt-to-Equity RatioN/A Current Ratio1.82 Quick Ratio1.82 Sales & Book Value Annual Sales$120,000.00 Price / Sales230.31 Cash FlowN/A Price / Cash FlowN/A Book Value$0.04 per share Price / Book15.75Miscellaneous Outstanding Shares43,869,000Free Float37,113,000Market Cap$27.64 million OptionableNot Optionable Beta2.40 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesMr. Ronald P. Erickson J.D. (Age 78)Founder, Chairman & Treasurer Comp: $366.04kMr. Phillip A. Bosua (Age 48)CEO & Director Comp: $663.76kMr. Peter Joseph ConleyCFO & Sr. VP of Intellectual PropertyMr. Leonardo TroutweinChief Marketing OfficerDr. James H. Anderson Jr.M.D., Chief Medical Officer and Chairman of Medical, Scientific & Regulatory Advisory BoardMr. Steven T. KentChief Product OfficerMr. Masanori TakeeSr. VP of Software EngineeringMore ExecutivesKey CompetitorsThe Arena GroupNYSE:ARENVenus AcquisitionNASDAQ:VENAMobiquity TechnologiesOTCMKTS:MOBQDAbits GroupNASDAQ:ABTSStran & Company, Inc.NASDAQ:SWAGView All Competitors KNWN Stock Analysis - Frequently Asked Questions How have KNWN shares performed in 2024? Know Labs' stock was trading at $0.5090 on January 1st, 2024. Since then, KNWN shares have increased by 23.8% and is now trading at $0.63. View the best growth stocks for 2024 here. How were Know Labs' earnings last quarter? Know Labs, Inc. (OTCMKTS:KNWN) posted its earnings results on Wednesday, August, 7th. The company reported ($0.04) earnings per share for the quarter. The business earned $0.38 million during the quarter. What other stocks do shareholders of Know Labs own? Based on aggregate information from My MarketBeat watchlists, some companies that other Know Labs investors own include Denali Therapeutics (DNLI), Co-Diagnostics (CODX), Onconova Therapeutics (ONTX), Sierra Oncology (SRRA), Acura Pharmaceuticals (ACUR), Actinium Pharmaceuticals (ATNM), AzurRx BioPharma (AZRX), CytoDyn (CYDY), (GBSN) (GBSN) and Home Depot (HD). How do I buy shares of Know Labs? Shares of KNWN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:KNWN) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 Media“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyFed launches fourth dollar overhaulStansberry ResearchAI healthcare stock poised for 36,996% growth?Behind the MarketsMost important medical advance in 100 yearsThe Oxford Club Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Know Labs, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.